B46.9

Clinical Causes: Inhalation of fungal spores present in the environment, especially in decaying organic matter like soil, compost, or rotting food. Ingestion of contaminated food or materials that harbor the fungi. Contact with contaminated surfaces or materials through skin wounds or cuts. Immunocompromised states such as leukemia, organ transplantation, diabetes mellitus, or use of immunosuppressive medications.

Key Symptoms: Fever and chills, often accompanied by a general feeling of illness. Redness, swelling, or pain at the site of infection, especially if skin is involved. Nasal congestion, sinus pain, or frequent nosebleeds if the sinuses are affected. Facial swelling, blurred vision, or swelling around the eyes in cases involving the facial region. Cough or shortness of breath if the lungs are involved. Black necrotic tissue may be observed in the nose or mouth when tissues begin to die. Headache, facial numbness, or facial paralysis in severe cases.

Diagnosis Path: Diagnosis often involves a combination of clinical examination, imaging studies such as CT or MRI scans to assess the extent of infection, and laboratory tests. A definitive diagnosis usually requires tissue biopsy and microscopic examination to identify the characteristic fungal elements. Blood tests and cultures can also assist in confirming the presence of the fungus, though they may not always be conclusive.

Treatment Protocols: Treatment of zygomycosis requires prompt and aggressive management. It usually involves a combination of antifungal medications, most notably amphotericin B. Surgical intervention may be necessary to remove dead or infected tissue, helping to control the spread of the infection. Managing any underlying health conditions, such as diabetes, is also crucial to improving outcomes. Early intervention significantly improves prognosis and reduces the risk of severe complications.